Human Neutrophils, Luminol-Amplified Chemiluminescence, Pancreatic Phospholipase A 2
Introduction
Human polymorphonuclear leukocytes (shorter: "neutrophils" or "PMNs") are highly specialised immune cells for phagocytosing and killing patho genic agents and micro-organisms. PMNs are among the first cells that migrate to the site of infection and they are equipped with a wide spectrum of bactericidal agents (Edwards, 1994) . Neutrophil NADPH oxidase that is required for the production of all reactive oxygen species (R O S) is activated by a variety of extracellular stimuli (Fantone and Ward, 1982) . Besides benefi cial effects that PMNs possess in host defence, they also may contribute to tissue damage if the extent of toxic (bactericidal) agents is not suffi ciently controlled or changed by modulators found in the extracellular environment of PMNs. For in stance, RO S as well as hydrolytic enzymes, re leased both from the stimulated PMNs, contribute significantly to the tissue injury in heart disease and rheumatoid arthritis (Prasad et al., 1990; Schil ler et al., 2000) .
Lysophospholids (LPLs) are often generated by the action of phospholipase A 2 (PLA 2) on the sn-2 # Both authors contributed equally to this work.
position of various phospholipid species. Neutro phils contain at least two different types of P L A 2: the cytosolic and the secretory form that are acti vated after cell stimulation (Marshall et al., 2000; review in: Six and Dennis, 2000) . The latter one is involved in inflammatory reactions (Murakami et al., 1997). The role of free fatty acids and their metabolites in the regulation of NADPH oxidase activity is well documented (Shiose and Suminoto, 2000) , whereas the role of LPLs in PMN functions is not yet sufficiently understood. Exogenous LPLs enhance the production of 0 2.-, i.e. NADPH oxidase activity (Ginsburg et al., 1989) and their role as signalling molecules affecting PMN func tion^) was postulated.
In this study LPLs were produced in the mem brane of PMNs by the addition of pancreatic PLA 2 (pPLA2). PMNs do not possess a specific receptor for this enzyme and, therefore, higher concentra tion of LPLs as well as free fatty acids for studying the PMN functions can be easily generated. The action of this enzyme results in a release of free fatty acids and the corresponding lysophospholip ids that we detected by matrix-assisted laser de sorption/ionisation time-of-flight mass spectrome try (M A LD I-TO F MS) in the PMN membrane. All together, digestion products of phospholipids significantly enhanced the respiratory burst activ-ity of human PMNs stimulated by chemotactic tripeptide (fMLP) or phorbol ester (PM A).
Materials and Methods

Material
Chemicals for the PMN purification, i.e. Hank's balanced salt solution (H B SS), Ficoll-Hypaque, dextran, heparin, and the stimulators, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) and phorbol myristoyl acetate (PM A) were purchased from Sigma (Deisenhofen, Germany). Luminol (5-amino-2,3-dihydrophthalazine-l,4-dione) was a product from Boehringer-Mannheim (Germany). Hog pancreas phospholipase A 2 (PLA 2) was purchased from Fluka (Neu Ulm, Germany), showing an activity of 561 U/mg protein (1 U cor responds to the amount of the enzyme that hy drolyses 1 [imol of phosphatidylcholine in 1 min at 37 °C and pH = 8.0).
All solvents (chloroform and methanol), 2,5-dihydroxybenzoic acid (D H B) and trifluoroacetic acid (TFA ) were also purchased from Fluka (G er many). All other chemicals were of highest com mercially available purity and they were used without any further purification.
Cell preparation
Polymorphonuclear leukocytes (PMNs) were isolated from the heparinised (10 U/ml) blood of healthy volunteers as described elsewhere (B0yum, 1964) . Briefly, after dextran-enhanced sedimentation of erythrocytes, the supernatant was subjected to Ficoll-density gradient centrifu gation. The remaining erythrocytes in the pellet were lysed three times for 1 min with distilled water. The resulting cell suspension was centri fuged and neutrophils obtained in the pellet were resuspended in H BSS and stored on ice until use. PMNs were used within 2 h after purification.
Chemiluminescence measurements
All chemiluminescence (C L) measurements were performed on a microplate luminometer MicroLumat LB 96 P (E G & G Berthold, Wildbad, Germany). Freshly prepared PMNs were in cubated with hog pancreas PLA 2 for 5 and 20 min. Before addition of the enzyme solution in H BSS (280.5 U/ml, final activity) PMNs were pre warmed at 37 °C for 5 min. PMNs were incubated with pPLA2 and reaction was terminated by spin ning-off the PMNs. The cellular pellet was once washed with H BSS and PMNs were resuspended in HBSS.
After preincubation, the corresponding stimula tors of the respiratory burst, namely fM LP (10-6 m, final concentration) or PMA (10-7 m, final con centration) were injected into the cell suspension and the CL response was monitored over 25 min. All CL experiments were repeated with three dif ferent cell preparations. CL after stimulation with fMLP or with PMA was measured as described. These results were compared with control PMNs (incubated at 37 °C with HBSS, for 5 and 20 min in the absence of PLA 2). The cell viability after purification and after treatment with pPLA 2 was checked by the trypan blue exclusion test.
Extraction o f lipids from human neutrophils
PMNs were incubated with pPLA2 as described above for CL measurement. PMNs were spun down and washed once with HBSS. The cellular pellet was resuspended in distilled water in order to decrease the content of inorganic ions in the sample, and the lipids were extracted according to the extraction procedure of Bligh and Dyer (1959) by vigorous mixing with chloroform/methanol mixture. After centrifugation, the chloroform layer was used for the mass spectrometric analysis.
Matrix and sample preparation fo r M A LD I-TO F mass spectrometry
For M A LD I-TO F MS, a 0.5 m 2,5-dihydroxybenzoic acid (D H B ) solution in methanol con taining 0.1% v/v trifluoroacetic acid (TFA ) was used. TFA was used because small amounts of TFA improve the signal-to-noise ratio of the lipid spectra (Schiller et al., 1999).
Chloroform was removed from the organic ex tracts of PMNs prepared as described above by vacuum centrifugation (Centrifugal Evaporator RC 10.10, Jouan, Winchester, Virginia, U SA ). A f ter that, 20 [il of 0.5 m D H B solution in methanol was added and the sample was vigorously mixed. All samples were applied as 1.8 jil droplets onto the sample plate and were rapidly dried under a warm stream of air.
All M A LD I-TO F mass spectra were acquired on a Voyager Biospectrometry workstation (PerSeptive Biosystems, Framingham, MA, U SA ). The system utilises a pulsed nitrogen laser, emitting at 337 nm. Pressure in the ion chamber was main tained between lx lO -7 and 4 x l0 -7 Torr. A two stage acceleration device allows to apply delayed extraction conditions (DE-m ode), improving both mass resolution and mass accuracy (Hillenkamp et al., 1991). The formed ions were accelerated by a 20 kV accelerating voltage within the ion source. In order to enhance the spectral resolution, the device was used in the reflector mode, so that the total field-free time-of-flight distance was 2 m. An internal calibration was performed by setting the peak of the protonated DHB-matrix to its appro priate value (155.034 Da). To enhance the repro ducibility, 128 single shots from the laser were averaged for each mass spectrum and each sample was run in duplicate. The laser power was kept about 10% over threshold to obtain the best signal-to-noise ratio. All lipid spectra (besides those for calibration) were acquired by using the "lowmass gate" at 400 Da to prevent the detector from the saturation by ions arising from matrix peaks (Petkovic et al., 2001a).
M ass spectrom etry
Results and Discussion
LPLs gained considerable scientific interest since they are important intermediates in the syn thesis of various PLs, as well as they were found to be important intercellular messengers. LPLs in fluence numerous cellular functions such as growth and differentiation (Goetzl and An, 1998; Ozaki et al., 1999; Sakai et al., 1994) . In studies on the effects of LPLs, these compounds are usually applied exogenously. In this study we tried to mimic "natural conditions" and to produce LPLs in the cell membrane by the addition of pPLA2 to the PMN suspension as well as to investigate the influence of LPLs on the RO S production. This enzyme was chosen among other P LA 2 enzymes since PMNs do not possess a specific receptor for pPLA2. Therefore, the observed effects are most probably mediated exclusively by products of the enzymatic digestion of phospholipids in the neu trophil membrane.
PMNs were incubated with pPLA 2 and the M A LD I-TO F mass spectra of the corresponding lipid extracts of the cells were recorded. The mass region of the LPLs of control PMNs is presented in for the proton and sodium adduct, respectively) are already present in unstimulated PMNs and the same holds for L P E 18:0 (the corresponding so dium adduct is clearly detectable at m/z = 504.3). All lysophospholipids give characteristic peak pat terns in their mass spectra. They are described in more details elsewhere (Petkovic et al., 2001b) . For instance, L P E as a neutral lysophospholipid requires one singly positively charged ion to be detectable in the positive ion mode. Therefore, two peaks should arise from the proton (LPE+H ) and the sodium adduct (LPE+N a). Besides these peaks, an additional peak is generated by the re placement of one proton by one sodium (LPEH+2Na). In the spectra of isolated L P E the most intense peak corresponds to the sodium adduct of LP E (LP E + Na). The further two peaks are of much lower intensity and there is great probability that they will be suppressed completely when a complex lipid mixture is analysed (Petkovic et al., 2001a; Schiller and Arnold, 2000) . That is the case in the positive ion M A L D I-TO F mass spectra of the lipid extract of human neutrophils, since under all expected peaks corresponding to L P E only a single one is detectable (at m/z = 504.3 corre sponding to the sodium adduct of L P E 18:0). Peak intensities in M A L D I-TO F mass spectra, however, do not properly reflect the concentration of an analyte, and therefore, an internal reference must be included for comparison of different spectra (Petkovic et al., 2001b) . In our case, the intensity of the matrix peak at m/z -551.1 was used as it was already done for the quantification of other lipid species like triglycerides (Asbury et al., 1999).
According to the relative intensity ratios of the LPL peaks (at m/z -524.3 and m/z = 546.3 that correspond to the proton and the sodium adducts of LPC 18:0, respectively) and the intensity of the characteristic matrix peak at m/z = 551.1 it is obvi ous that the intensity of peaks arising from LPC increased after 5 minutes incubation with PLA 2. After 20 min incubation of PMNs with PLA 2, however, the intensity of these peaks decreased (Fig. lc ) while the intensity of the following peaks increased: An additional peak at m/z = 454.3 was clearly detectable, and it most probably arises from the proton adduct of L P E 16:0. Additionally, peaks at m/z = 496.3 and m/z = 518.3 (not labelled in the figure) that correspond to the proton and the sodium adducts of LPC 16:0, respectively, ap peared. The identity of the peak at m/z= 520.3 is not completely clear, and it might be attributed to the proton adduct of LPC 18:2, although this is of rather low probability. Finally, a clear increase of the peak at m/z = 504.3 corresponding to the pro ton adduct of LPE 18:0 was observed. This might indicate that LPC 18:0 generated after 5 min in the presence of PLA 2 was reacylated by PMNs after 20 min of incubation, and that other abundant PL species were also digested by PLA 2.
After changes in the LPL region were detected, one would also expect changes in the phospholipid region. This region is, however, crowded by peaks and can be rather difficult analysed. The most in tense peaks arise form PC, since (a) this species is the most abundant cellular phospholipid, and (b) it is most easily detectable by M A LD I-TO F MS (Schiller et al., 1999) . This is the first problem towards the analysis of this mass region. A second problem stems from the rather similar molecular masses of other abundant cellular lipids, mainly PE and PS, that can give a number of overlapping peaks. We were not able to monitor the corre sponding changes in that mass region, but due to above described difficulties, we cannot rule changes completely out.
The respiratory burst response of human PMNs was investigated by luminol-amplified chemiluminescence. It is known that PMNs release RO S but also produce them intracellularly (Bender and Van Epps, 1983) . Since luminol is a cell membrane per meable agent it detects both extra-and intracellu lar RO S production (Edwards, 1996; Müller and Arnhold, 2001 ).
In Fig. 2 , a typical CL curve of human neutro phils treated with pPLA2 for 5 min and stimulated afterwards with phorbol ester, PMA, is shown. The chemiluminescence of the corresponding con trol was also measured and provides by far lower CL intensity. The time of injection of PMA into the PMN suspension is indicated by an arrow in the figure. The typical CL response to PMA stimu lation is a monophasic curve with a single maxi mum and it is generally accepted that CL in this case is caused by intracellular RO S generation (Bender and Van Epps, 1983) . It is obvious that incubation of PMNs with pPLA2 results in signifi cantly higher CL response. Significant increase was observed also when the cells were stimulated with the chemotactic tripeptide, fMLP (data not presented). The only difference was that in the case of fMLP-stimulated cells, the typical response is a biphasic curve and after treatment of PMNs with pPLA 2, both phases were significantly en hanced (data not shown).
In additional experiments also the overall RO S production was determined by integrating the cor responding CL curves. For each incubation of neu trophils with pPLA2 the corresponding control was also performed in parallel, i.e. cells were incu bated at 37 °C for 5 and 20 min with H BSS buffer. Integral R L U / s -values that reflect the overall RO S production -for control cells as well as for those treated with pPLA 2 for 5 and 20 min are given in Table I .
The overall RO S production significantly increased after 5 and 20 min incubation with PLA 2 in comparison to the corresponding control. The most pronounced effect was obtained for PMAstimulated PMNs incubated for 5 min with PLA 2 (an about twenty-fold increase in CL), whereas af ter 20 min incubation this effect was by far less pronounced (cf. Table I ).
In the case of the fMLP-stimulated cells, an about tenfold increase was obtained after 20 min , 1997) . Since pro tein kinase C (PK C ) plays an important role in signalling pathways leading to the NADPH oxi dase activation in human PMNs, we assume that the increase in the amount of LPLs in the mem brane would lead to an increased activity of PKC, and concomitantly enhanced RO S production. Additionally, the second product of pPLA 2 diges tion of phospholipids from the membrane are free fatty acids. Their role in regulation of the NADPH oxidase activity was recently demonstrated (Shiose and Sumimoto, 2000) . Due to the "low mass gate" applied for M A L D I-T O F mass spectrometry we were not able to detect free fatty acids in the lipid extract of human PMNs and in general, de-tection of free fatty acids by M A LD I-TO F MS is difficult. However, their simultaneous presence is clearly indicated by an increase in the lysophospholipid concentration in the lipid extract of hu man neutrophils. Therefore, free fatty acids and / or their metabolites also contribute to the ob served effects.
We have shown recently that exogenously added LPC acts in a completely different way, i.e. this L PL inhibits under those circumstances in a concentration-dependent manner the CL response of PMA-stimulated as well as the first phase of fM LP -stimulated PMNs, whereas the second phase was enhanced (J. Müller et al., submitted). We have also found that this LPL is incorporated in the membrane of PMNs and therefore, it is of great probability that the effects described in this report are mediated also by the released fatty acids and/or their metabolites. Although the exog enous addition of LPLs might be helpful for eluci dating the effects of a single species, treatment of PMNs with pPLA 2 is -to our opinion -by far more related to the situation under in vivo condi tions than the exogenous addition of lysophospholipids.
In conclusion, it has been clearly shown that the treatment of human PMNs with pancreatic phos pholipase A 2 leads to the increase in LPL concen tration and subsequently to an increase in the pro duction of reactive oxygen species. This approach might become useful for studying the involvement of LPLs in intracellular signalling pathways, since in this way the receptor-mediated -either for P LA 2 or for various further LPLs -pathways can be completely excluded. 
